These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 26743209)

  • 1. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
    Madiraju AK; Erion DM; Rahimi Y; Zhang XM; Braddock DT; Albright RA; Prigaro BJ; Wood JL; Bhanot S; MacDonald MJ; Jurczak MJ; Camporez JP; Lee HY; Cline GW; Samuel VT; Kibbey RG; Shulman GI
    Nature; 2014 Jun; 510(7506):542-6. PubMed ID: 24847880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin--mode of action and clinical implications for diabetes and cancer.
    Pernicova I; Korbonits M
    Nat Rev Endocrinol; 2014 Mar; 10(3):143-56. PubMed ID: 24393785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect.
    Saisho Y
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):196-205. PubMed ID: 25772174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The target of metformin in type 2 diabetes.
    Ferrannini E
    N Engl J Med; 2014 Oct; 371(16):1547-8. PubMed ID: 25317875
    [No Abstract]   [Full Text] [Related]  

  • 7. Angelica gigas Ameliorates Hyperglycemia and Hepatic Steatosis in C57BL/KsJ-db/db Mice via Activation of AMP-Activated Protein Kinase Signaling Pathway.
    Bae UJ; Choi EK; Oh MR; Jung SJ; Park J; Jung TS; Park TS; Chae SW; Park BH
    Am J Chin Med; 2016; 44(8):1627-1638. PubMed ID: 27852130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposal for the locus of metformin's clinical action: potentiation of the activation of pyruvate kinase by fructose-1,6-diphosphate.
    McCarty MF
    Med Hypotheses; 1999 Feb; 52(2):89-93. PubMed ID: 10340287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production.
    Kim SJ; Quan HY; Jeong KJ; Kim DY; Kim Gw; Jo HK; Chung SH
    J Agric Food Chem; 2014 Jan; 62(2):434-42. PubMed ID: 24354358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
    Wiernsperger NF
    Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of the AMPK gamma 1 subunit in metformin suppression of liver glucose production.
    An H; Wang Y; Qin C; Li M; Maheshwari A; He L
    Sci Rep; 2020 Jun; 10(1):10482. PubMed ID: 32591547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK.
    Wang Y; An H; Liu T; Qin C; Sesaki H; Guo S; Radovick S; Hussain M; Maheshwari A; Wondisford FE; O'Rourke B; He L
    Cell Rep; 2019 Nov; 29(6):1511-1523.e5. PubMed ID: 31693892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin's Therapeutic Efficacy in the Treatment of Diabetes Does Not Involve Inhibition of Mitochondrial Glycerol Phosphate Dehydrogenase.
    MacDonald MJ; Ansari IH; Longacre MJ; Stoker SW
    Diabetes; 2021 Jul; 70(7):1575-1580. PubMed ID: 33849997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and Molecular Mechanisms of Metformin Action.
    LaMoia TE; Shulman GI
    Endocr Rev; 2021 Jan; 42(1):77-96. PubMed ID: 32897388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
    Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
    J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin: an update.
    Kirpichnikov D; McFarlane SI; Sowers JR
    Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Effects of Metformin in Humans.
    Adeva-Andany MM; Rañal-Muíño E; Fernández-Fernández C; Pazos-García C; Vila-Altesor M
    Curr Diabetes Rev; 2019; 15(4):328-339. PubMed ID: 30306875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
    Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
    Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.